Investments
5About Grampian BioPartners
Grampian Bio-partners is a small venture capital fund founded by Andy Porter in partnership with founding scientists of Haptogen. They invests in early stage companies focused on immuno-technology and biologics platforms.
Want to inform investors similar to Grampian BioPartners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Grampian BioPartners Investments
5 Investments
Grampian BioPartners has made 5 investments. Their latest investment was in Vital Metrix as part of their Series A on October 10, 2018.
Grampian BioPartners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/3/2018 | Series A | Vital Metrix | $2.99M | No | 1 | |
10/4/2017 | Seed VC | |||||
3/6/2009 | Unattributed | |||||
Other Investors | ||||||
Other Investors |
Date | 10/3/2018 | 10/4/2017 | 3/6/2009 | ||
|---|---|---|---|---|---|
Round | Series A | Seed VC | Unattributed | Other Investors | Other Investors |
Company | Vital Metrix | ||||
Amount | $2.99M | ||||
New? | No | ||||
Co-Investors | |||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
